Literature DB >> 15060203

The developing kidney and environmental toxins.

Michael J Solhaug1, Philip M Bolger, Pedro A Jose.   

Abstract

The effects of environmental chemicals, drugs, and physical agents on the developing kidney are influenced by the state of renal development and maturation. The development of the kidney, the major excretory organ after birth, consists of 3 stages: the pronephros, or cervical kidney; mesonephros, or thoracic kidney; and metanephros, or abdominal kidney, the definitive kidney. In humans, nephrogenesis and organogenesis occur from the 6th to the 36th weeks of gestational age. After 36 weeks, nephrogenesis is complete and each kidney has a full complement of nephrons. The extent of chemical-induced renal toxicity is related, in part, to the efficiency in which the particular compound is transported by renal tubules. Because renal tubular transport capacities vary with maturation, the degree of nephrotoxicity may also vary with maturation. The signs and symptoms of nephrotoxicity can appear acutely or insidiously. Unexplained acute renal failure, chronic mild proteinuria, or even hypertension can be a manifestation of nephrotoxic agents. Species differences occur, thus the need for studies in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060203

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

1.  Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury.

Authors:  Kathryn A Seely; Joseph H Holthoff; Samuel T Burns; Zhen Wang; Keshari M Thakali; Neriman Gokden; Sung W Rhee; Philip R Mayeux
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.

Authors:  Wei Zhao; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 3.  Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.

Authors:  Craig G Hartford; Kasia S Petchel; Hani Mickail; Susana Perez-Gutthann; Mary McHale; John M Grana; Paula Marquez
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  The long-term renal and cardiovascular consequences of prematurity.

Authors:  Carolyn L Abitbol; Maria M Rodriguez
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

Review 5.  Ontogeny of drug elimination by the human kidney.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-12-06       Impact factor: 3.714

Review 6.  Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.

Authors:  Melvin Khee-Shing Leow
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

7.  Histology Atlas of the Developing Mouse Urinary System With Emphasis on Prenatal Days E10.5-E18.5.

Authors:  Susan A Elmore; Sanam L Kavari; Mark J Hoenerhoff; Beth Mahler; Brittany E Scott; Koichi Yabe; John C Seely
Journal:  Toxicol Pathol       Date:  2019-10-10       Impact factor: 1.902

Review 8.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

9.  Maternal diabetes modulates renal morphogenesis in offspring.

Authors:  Stella Tran; Yun-Wen Chen; Isabelle Chenier; John S D Chan; Susan Quaggin; Marie-Josée Hébert; Julie R Ingelfinger; Shao-Ling Zhang
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

Review 10.  Toxic environmental exposures and kidney health in children.

Authors:  Darcy K Weidemann; Virginia M Weaver; Jeffrey J Fadrowski
Journal:  Pediatr Nephrol       Date:  2015-10-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.